-
Mashup Score: 6Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters, prompts life-changing decisions - Mayo Clinic News Network - 6 month(s) ago
(Sisters left to right: Chris Swatfager, Cindy Larson, Carrie Patnode and Amy Scheid. Photo is courtesy of Chris Swatfager.) Sisters […]
Source: newsnetwork.mayoclinic.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Validate User - 9 month(s) ago
We are sorry, but we are experiencing unusual traffic at this time. Please help us confirm that you are not a robot and we will take you to your
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
The Institute of Cancer Research, London, has hailed the ‘life-changing’ decision by NICE to recommend that the targeted drug olaparib can be used for NHS patients with both early-stage breast cancer and prostate cancer.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Today - 06/04/2023 - BBC Sounds - 1 year(s) ago
News and current affairs, including Sports Desk, Weather and Thought for the Day.
Source: BBCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1
The Institute of Cancer Research, London, has hailed the ‘life-changing’ decision by NICE to recommend that the targeted drug olaparib can be used for NHS patients with both early-stage breast cancer and prostate cancer.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 8Women in Science: Mary-Claire King - 1 year(s) ago
Mary-Claire King’s life and work serves as an ideal for scientific investigation and using our knowledge to empower communities.
Source: The Jackson LaboratoryCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 5The World Tonight - 16/03/2023 - BBC Sounds - 1 year(s) ago
In depth reporting, intelligent analysis and breaking news from a global perspective
Source: BBCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2 - PubMed - 1 year(s) ago
Women diagnosed with breast cancer and known to carry germline PVs in BRCA1, BRCA2, CHEK2, or PALB2 are at substantially increased risk of CBC and may benefit from enhanced surveillance and risk reduction strategies.
Source: PubMedCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Profiling of the genetic features of Chinese patients with gastric cancer with HRD germline mutations in a large-scale retrospective study - 1 year(s) ago
Background Approximately 10% of gastric cancers (GCs) are associated with strong familial clustering and can be attributed to genetic predisposition. Homologous recombination deficiency (HRD) leads to genomic instability and accumulation of genetic variations, playing an important role in the development and progression of cancer. We aimed to delineate the germline mutation characteristics of…
Source: Journal of Medical GeneticsCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer - 1 year(s) ago
AbstractBackground. Genetic predisposition is has been identified as a cause of cancer, yet little is known about the role of adult cancer predisposition syndro
Source: OUP AcademicCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
RT @MayoCancerCare: Mayo Clinic’s DNA study reveals #BRCA1 mutations in 3 sisters, prompts life-changing decisions: https://t.co/9cJ9fyQ2Iy